MET — Metlife Income Statement

0.000.00%

Last trade - 00:00

FinancialsConservativeLarge CapSuper Stock

Annual income statement for Metlife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Total Premiums Earned
Net Investment Income
Realized & Unrealized Gains / Losses
Other Revenue
Total Revenue	67,842	68,469	68,870	66,851	71,048
Losses, Benefits, and Adjustments
Amortization of Policy Acquisition Costs
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses	60,002	59,258	61,468	63,698	64,327
Operating Profit	7,840	9,211	7,402	3,153	6,721
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	6,927	8,518	6,364	2,162	5,622
Provision for Income Taxes
Net Income After Taxes	5,418	6,876	5,302	1,602	4,444
Minority Interest
Net Income Before Extraordinary Items
Net Income	5,407	6,855	5,284	1,578	4,426
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,191	6,654	5,099	1,380	4,226
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.68	7.7	6.31	1.81	5.94
Dividends per Share